RAND Europe Spotlight: 2022-2023

Read our annual review

Good decisions require good evidence and, as ever, our goal is to provide policymakers with the objective, high-quality research and analysis needed to develop effective, lasting solutions. In 2022 we tackled a range of existing and emerging issues, including the security risks of research collaboration with Chinese partners, the complex factors influencing medicines R&D financing, the potentially transformative impact of quantum technology in the life sciences, and actions to support disadvantaged groups obtain green jobs as economies transform.

Read the report

References for Spotlight 2022-2023

The true scale of disease burden

More research on the burden of disease

Healthy workplaces

Fresh perspectives

Improving how medicines R&D is financed for patient benefit

Who benefits?

Steps to sustainability

More research on environmental sustainability

Trafficking human beings

Dutch planning for Brexit

Chinese influence in British universities

On the cusp

Sound proposals

Building trust

Removing barriers to diversity and inclusion in the military

Social value

FiMT Research Centre

Network of ideas

On the horizon

30th Anniversary

Previous Years' Spotlights